Navigation Links
FDA approves drug tested by Scottsdale Healthcare and TGen
Date:9/6/2013

SCOTTSDALE, Ariz., Sept. 6, 2013 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Abraxane for patients with advanced pancreatic cancer, following 7 years of rigorous clinical trials overseen by Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).

(Logo: http://photos.prnewswire.com/prnh/20120201/DC45876)

Abraxane, the brand name for nab-paclitaxel, was approved for use in combination with gemcitabine, the previous standard drug therapy, following a large scale international clinical trial headed by Dr. Daniel D. Von Hoff, TGen Physician-in-Chief and Chief Scientific Officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and TGen.

"This is a new standard for treatment of metastatic pancreatic cancer that could become the backbone for other new treatment regimens," said Dr. Von Hoff, echoing the analysis he presented earlier this year at the annual meeting of the American Society of Clinical Oncology (ASCO). "The fact that Abraxane plus gemcitabine demonstrated an overall survival benefit is a significant step forward in offering new hope for our patients."

Dr. Von Hoff was the Principal Investigator of MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial), the Phase III clinical study of 861 cancer patients at 121 sites in North America, Europe and Australia.

The study found that the combination of Abraxane and gemcitabine extended median overall survival by nearly 2 months, compared to gemcitabine alone — extending median survival to 8.5 months, from 6.7 months. The one-year median survival of patients increased to 35 percent, from 22 p
'/>"/>

SOURCE Scottsdale Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
2. FDA Approves NDA Supported By MedAvante Central Ratings
3. Cardinal Health Board Of Directors Approves Cash Dividend; Authorizes New $750 Million Share Repurchase Program
4. FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
5. Specialty Pharmacy Certification Board (SPCB) Approves Content for Certified Specialty Pharmacist (CSP) Certification Exam
6. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
7. FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults
8. Baby Boomers Should Get Tested for Hepatitis C
9. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
10. Scottsdale Healthcare, TGen study shows Abraxane/gemcitabine combination extends survival of pancreatic cancer patients
11. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that ... in its catalogue: Needle-Free Delivery: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report ... and commercial prospects What does the future ... brand new report shows you the potential ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... 15, 2007 /PRNewswire/ -- Solstice,Neurosciences, Inc. today reported ... of Botulinum Toxin Type B,Injectable Solution (Myobloc(R)) recently ... Disorders Society in,Istanbul, Turkey. , This was the ... of escalating treatment doses of 10,000 Units, 12,500,Units, ...
... Survival Benefit Demonstrated for an AI Over Tamoxifen ... 15 June 2007: Analysis of the entire,population of ... breast cancer can be significantly improved by switching ... 95' (ARNO 95) study, published online in The,Journal ...
Cached Medicine Technology:Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 2Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 3Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5
(Date:8/29/2014)... August 30, 2014 Indosoft, Inc. ... software, announces the release of its most advanced contact ... number of new features as well as updates to ... , Q-Suite functionality on the presentation side has ... into the script builder. This WYSIWYG editor ...
(Date:8/29/2014)... AGH Healthy Happenings, a community education and ... at Atlantic General Hospital, are now offering area ... to no-cost blood pressure screenings at a local pharmacy, ... local sports tournaments. , In addition, the ... disease management and falls prevention workshops on various dates ...
(Date:8/29/2014)... Everyone dreams about looking absolutely great, ... , According to the latest review published by Daily ... imagined with the right tips and recommendations. , ... an amazingly effective and fast method of looking perfectly. ... program is really efficient when it comes to the ...
(Date:8/29/2014)... August 29, 2014 Daily Gossip reveals in its ... created by a former cold sores patient who suffered from this ... Ellie Gadsby, who decided to share her tips and advices, but ... , The author of the Get Rid of Cold Sores Fast ... years, while in the least 4 years outbreaks have become more ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica in ... of naturally curing this disease. , The program promises ... cure in only one week. This is described as a ... huge sacrifices. , Moreover, with this new method patients ... sciatica in just 8 minutes. , Interested customers can ...
Breaking Medicine News(10 mins):Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3Health News:Shapeshifter Yoga Review Reveals Kris Fondran's New Body Shaping and Fat Loss Program 2Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2
... DIEGO, Oct. 19 RESMED INC. (NYSE: RMD ... will release its,earnings for this first quarter of fiscal ... earnings press release after 1:00 p.m. Pacific,Time and will ... trends, and future outlook. The conference call is ...
... woman, the less the idea bothered her , , FRIDAY, ... with the idea of childlessness than men, new research ... in how each gender views the pressures of parenthood. ... parenting and parenthood mean different things," said study author ...
... at home less likely to pass exams, research shows , ... smoke a threat to teen health, it can also affect ... at Temple University found that 16- and 18-year-olds exposed to ... pass standardized tests than their peers. , They reached this ...
... Fans Have Chance To Meet Newest Wings and Help Two Charitable Causes ... ... Oct. 19 The Red Wings support of two October,community initiatives will ... for the team,s smoke detector,collection initiative and the first annual Breast Cancer ...
... Oct. 19 PulseLearning,(which was founded in 1999 with ... a second-hand computer set up in a child,s bedroom ... fastest growing IT company in,Ireland at the ,2007 Deloitte ... now in their eighth year, rank the 50 fastest,growing ...
... Mary Remotti,feels when her body is touched by the even ... bed washes over her like the heat of an intense,fire. ... pain,which she cannot escape. Remotti is an 18-year-old Connecticut ... confined to her bed suffering from Reflex Sympathetic,Dystrophy (RSD) also ...
Cached Medicine News:Health News:ResMed to Webcast First Quarter 2008 Earnings Conference Call 2Health News:Childlessness Bothers Men More Than Women 2Health News:Childlessness Bothers Men More Than Women 3Health News:Secondhand Smoke Hurts Kids' Grades 2Health News:Drake, Rafalski to Sign Autographs at Hockeytown Authentics 2Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 2Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 3Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 4Health News:Connecticut Girl Fights Rare Neurological Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: